Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

653.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 655.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 120.21m
  • Volume: 81,141
  • Market Cap: £784.95m
  • RiskGrade: 125
  • Beta: 0.03

Latest ShareCast News

Oxford Biomedica acquires US viral vector facility

By Iain Gilbert

Date: Tuesday 07 Oct 2025

(Sharecast News) - Cell and gene therapy outfit Oxford Biomedica said on Tuesday that it had agreed to acquire a viral vector manufacturing site in Rockville, Maryland, from ABL for $60m in cash, expanding its US footprint and strengthening its contract development and manufacturing offering.

OXB Regulatory News

Acquisition of US viral vector facility 07-Oct-2025 07:00 RNS
Total Voting Rights 01-Oct-2025 07:00 RNS
Interim Results for 6 months ended 30 June 2025 23-Sep-2025 07:00 RNS
Total Voting Rights 01-Sep-2025 07:00 RNS
PDMR Dealings 22-Aug-2025 15:36 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 653.00p
Change Today 5.00p
% Change 0.77 %
52 Week High 655.00p
52 Week Low 232.50p
Volume 81,141
Shares Issued 120.21m
Market Cap £784.95m
Beta 0.03
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

OXB Dividends

No dividends found

Trades for 09-Oct-2025

Time Volume / Share Price
10:50 779 @ 652.54p
10:49 183 @ 653.00p
10:49 56 @ 653.00p
10:49 143 @ 653.00p
10:43 2,308 @ 650.26p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page